Takashi Seto

Takashi Seto

UNVERIFIED PROFILE

Are you Takashi Seto?   Register this Author

Register author
Takashi Seto

Takashi Seto

Publications by authors named "Takashi Seto"

Are you Takashi Seto?   Register this Author

100Publications

2577Reads

5Profile Views

Therapies after first-line afatinib in patients with m NSCLC in Japan: retrospective analysis of LUX-Lung 3.

Future Oncol 2020 Feb 10;16(4):49-60. Epub 2020 Jan 10.

Third Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2019-0659DOI Listing
February 2020

Phase II study of vinorelbine plus carboplatin with concurrent radiotherapy in elderly patients with non-small cell lung cancer.

Jpn J Clin Oncol 2019 Dec 5. Epub 2019 Dec 5.

Department of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyz179DOI Listing
December 2019

Acute Generalized Exanthematous Pustulosis Caused by the Combination of Pembrolizumab Plus Chemotherapy in a Patient With Squamous-Cell Carcinoma.

Clin Lung Cancer 2019 Nov 20. Epub 2019 Nov 20.

Department of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2019.11.009DOI Listing
November 2019

The Influence of Clinical T Factor on Predicting Pathologic N Factor in Resected Lung Cancer.

Ann Thorac Surg 2019 10 16;108(4):1080-1086. Epub 2019 May 16.

Department of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2019.04.026DOI Listing
October 2019

Single-arm, multicentre, phase II trial of nivolumab for unresectable or recurrent thymic carcinoma: PRIMER study.

Eur J Cancer 2019 May 13;113:78-86. Epub 2019 Apr 13.

Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.03.012DOI Listing
May 2019

ALK testing methods: is there a winner or loser?

Expert Rev Anticancer Ther 2019 Mar 28;19(3):237-244. Epub 2018 Dec 28.

a Department of Thoracic Oncology , National Kyushu Cancer Center , Fukuoka , Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2019.1562343DOI Listing
March 2019

Pneumonectomy after induction chemoradiotherapy for locally advanced non-small cell lung cancer: should curative intent pulmonary resection be avoided?

Surg Today 2019 Mar 4;49(3):197-205. Epub 2019 Jan 4.

Department of Thoracic Oncology, National Kyushu Cancer Center, 3-1-1, Notame, Minami-ku, Fukuoka City, 811-1395, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00595-018-1751-7DOI Listing
March 2019

Co-expression of IDO1 and PD-L1 in lung squamous cell carcinoma: Potential targets of novel combination therapy.

Lung Cancer 2019 02 10;128:26-32. Epub 2018 Dec 10.

Kyushu Central Hospital of the Mutual Aid Association of Public School Teachers, 3-23-1 Shiobaru, Minami-ku, Fukuoka, 815-8588, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.12.008DOI Listing
February 2019

Atezolizumab in non-squamous non-small cell lung cancer.

J Thorac Dis 2018 Sep;10(Suppl 26):S3155-S3159

Department of Thoracic Oncology, National Kyushu Cancer Center, Minami-ku, Fukuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2018.07.92DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186653PMC
September 2018

Spotlight on lorlatinib and its potential in the treatment of NSCLC: the evidence to date.

Onco Targets Ther 2018 22;11:5093-5101. Epub 2018 Aug 22.

Department of Thoracic Oncology, National Kyushu Cancer Center, Minami-ku, Fukuoka, Japan.

View Article

Download full-text PDF

Source
https://www.dovepress.com/spotlight-on-lorlatinib-and-its-po
Publisher Site
http://dx.doi.org/10.2147/OTT.S165511DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110295PMC
August 2018

Is prophylactic cranial irradiation (PCI) needed in patients with extensive-stage small cell lung cancer showing complete response to first-line chemotherapy?

Radiother Oncol 2018 06 7;127(3):344-348. Epub 2018 May 7.

Third Department of Internal Medicine, Wakayama Medical University, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2018.04.010DOI Listing
June 2018

Clinicopathological features of younger (aged ≤ 50 years) lung adenocarcinoma patients harboring the EML4-ALK fusion gene.

Thorac Cancer 2018 05 8;9(5):563-570. Epub 2018 Mar 8.

Department of Thoracic Oncology and Clinical Research Institute, National Kyushu Cancer Center, Fukuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1759-7714.12616DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928374PMC
May 2018

Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non-Small-Cell Lung Cancer.

J Clin Oncol 2018 05 29;36(14):1405-1411. Epub 2018 Mar 29.

Yi-Long Wu and Jin-Ji Yang, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou; Shun Lu, Jiao Tong University, Shanghai; Jianying Zhou, First Affiliated Hospital of Zhejiang University, Hangzhou, People's Republic of China; James Chih-Hsin Yang, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Republic of China; Dong-Wan Kim, Seoul National University Hospital; Myung-Ju Ahn, Samsung Medical Center, Seoul, South Korea; Takashi Seto, National Kyushu Cancer Center, Fukuoka; Noboru Yamamoto, National Cancer Center Hospital, Tokyo; Toshiaki Takahashi, Shizuoka Cancer Center, Shizuoka; Takeharu Yamanaka, Yokohama City University School of Medicine, Yokohama; Koichi Goto, National Cancer Center Hospital East, Kashiwa, Japan; Allison Kemner and Debasish Roychowdhury, OxOnc Development, Princeton, NJ; Nirvan Consultants, Lexington, MA; Jolanda Paolini and Tiziana Usari, Pfizer, Milan, Italy; and Keith D. Wilner, Pfizer, La Jolla, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.5587DOI Listing
May 2018

Safety and pharmacokinetics of DS-6051b in Japanese patients with non-small cell lung cancer harboring fusions: a phase I study.

Oncotarget 2018 May 4;9(34):23729-23737. Epub 2018 May 4.

Department of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, Minami-ku, Fukuoka-shi, Fukuoka 811-1395, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.25263DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955103PMC
May 2018

Real world treatment and outcomes in EGFR mutation-positive non-small cell lung cancer: Long-term follow-up of a large patient cohort.

Lung Cancer 2018 03 9;117:14-19. Epub 2018 Jan 9.

Department of Medical Oncology, Izumi Municipal Hospital, 4-10-10 Fuchu, Izumi, 594-0071, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.01.005DOI Listing
March 2018

Detection of epidermal growth factor receptor gene T790M mutation in cytology samples using the cobas EGFR mutation test.

Lung Cancer 2017 09 11;111:190-194. Epub 2017 Jul 11.

Division of Pulmonary Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, 329-0498, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.07.015DOI Listing
September 2017

Pulmonary Resection for Synchronous M1b-cStage IV Non-Small Cell Lung Cancer Patients.

Ann Thorac Surg 2017 May 15;103(5):1594-1599. Epub 2016 Nov 15.

Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2016.08.098DOI Listing
May 2017

Three-Year Follow-Up of an Alectinib Phase I/II Study in ALK-Positive Non-Small-Cell Lung Cancer: AF-001JP.

J Clin Oncol 2017 May 15;35(14):1515-1521. Epub 2017 Mar 15.

Tomohide Tamura, St Luke's International Hospital; Yuichiro Ohe, National Cancer Center Hospital; Hiroshi Kuriki, Tadashi Shimada, and Tomohiro Tanaka, Chugai Pharmaceutical; Kengo Takeuchi, Japanese Foundation for Cancer Research; Makoto Nishio, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo; Katsuyuki Kiura, Okayama University Hospital, Okayama; Takashi Seto, National Kyusyu Cancer Center, Fukuoka; Kazuhiko Nakagawa, Kindai University, Osaka-Sayama; Makoto Maemondo, Miyagi Cancer Center, Natori; Akira Inoue, Tohoku University, Sendai; Toyoaki Hida, Aichi Cancer Center, Nagoya; Hiroshige Yoshioka, Kurashiki Central Hospital, Kurashiki; Masao Harada, Hokkaido Cancer Center, Sapporo; Naoyuki Nogami, National Hospital Organization Shikoku Cancer Center, Matsuyama; and Haruyasu Murakami, Shizuoka Cancer Center, Shizuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.5749DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455704PMC
May 2017

W'ALK' Into the Next Stage.

Clin Lung Cancer 2017 03 26;18(2):122-126. Epub 2016 Oct 26.

Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.10.005DOI Listing
March 2017

Prognostic Factors for Survival after Resection of Pulmonary Metastases from Colorectal Carcinoma.

Ann Thorac Cardiovasc Surg 2016 19;22(1):6-11. Epub 2015 Aug 19.

Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Fukuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5761/atcs.oa.14-00345DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981774PMC
December 2016

Mutations of the EGFR, K-ras, EML4-ALK, and BRAF genes in resected pathological stage I lung adenocarcinoma.

Surg Today 2016 Sep 28;46(9):1091-8. Epub 2015 Dec 28.

Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00595-015-1295-zDOI Listing
September 2016

Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108L.

J Clin Oncol 2016 09 28;34(27):3248-57. Epub 2016 Mar 28.

Yoshiko Urata, Miyako Satouchi, and Shunichi Negoro, Hyogo Cancer Center, Akashi; Nobuyuki Katakami and Reiko Kaji, Institute of Biomedical Research and Innovation; Daichi Fujimoto, Kobe City Medical Center General Hospital, Kobe; Satoshi Morita, Kyoto University Graduate School of Medicine, Kyoto; Hiroshige Yoshioka, Kurashiki Central Hospital, Kurashiki; Takashi Seto, National Kyushu Cancer Center; Yoichi Nakanishi, Kyushu University, Graduate School of Medical Sciences, Fukuoka; Yasuo Iwamoto and Masashi Kanehara, Hiroshima City Hospital, Hiroshima; Norihiko Ikeda, Tokyo Medical University, Tokyo; Haruyasu Murakami, Shizuoka Cancer Center, Shizuoka; Haruko Daga, Osaka City General Hospital; Fumio Imamura, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka; Isao Goto, Osaka Medical College, Takatsuki; Hideo Saka, National Hospital Organization Nagoya Medical Center; Tetsuya Oguri, Nagoya City University Graduate School of Medical Sciences, Nagoya; Shunichi Sugawara, Sendai Kousei Hospital, Sendai; Naoyuki Nogami, National Hospital Organization Shikoku Cancer Center, Matsuyama; and Kazuhiko Nakagawa, Kinki University Faculty of Medicine, Osaka-Sayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.4154DOI Listing
September 2016

Post-recurrence survival of elderly patients 75 years of age or older with surgically resected non-small cell lung cancer.

Surg Today 2016 Apr 13;46(4):430-6. Epub 2015 Jun 13.

Department of Thoracic Oncology, National Kyushu Cancer Center, Notame 3-1-1, Minami-ku, Fukuoka, 811-1395, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00595-015-1200-9DOI Listing
April 2016

Safety and tolerability of AZD5363 in Japanese patients with advanced solid tumors.

Cancer Chemother Pharmacol 2016 Apr 1;77(4):787-95. Epub 2016 Mar 1.

Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-016-2987-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819940PMC
April 2016

Updated Evidence on the Mechanisms of Resistance to ALK Inhibitors and Strategies to Overcome Such Resistance: Clinical and Preclinical Data.

Oncol Res Treat 2015 13;38(6):291-8. Epub 2015 May 13.

Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000430852DOI Listing
March 2016

Influence of the distance between home and the hospital on patients with surgically resected non-small-cell lung cancer.

Eur J Cardiothorac Surg 2016 Mar 22;49(3):842-6. Epub 2015 Jul 22.

Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan Clinical Research Institute, National Kyushu Cancer Center, Fukuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ejcts/ezv253DOI Listing
March 2016

Are Anthracycline-Based Regimens Truly Indicated To Be the Standard Chemotherapy Regimen for Thymic Carcinoma?

J Thorac Oncol 2016 Jan;11(1):115-21

Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2015.09.007DOI Listing
January 2016

Insights into brain metastasis in patients with ALK+ lung cancer: is the brain truly a sanctuary?

Cancer Metastasis Rev 2015 Dec;34(4):797-805

Department of Thoracic Oncology, National Kyushu Cancer Center, 3-1-1 Notame, Minami-ku, Fukuoka, 811-1395, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10555-015-9592-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661196PMC
December 2015

The Role of Radiotherapy in the Treatment of Small-Cell Lung Cancer.

Curr Treat Options Oncol 2015 Dec;16(12):56

Department of Thoracic Oncology, National Kyushu Cancer Center, 3-1-1 Notame, Minami-ku, Fukuoka, 811-1395, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-015-0372-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605961PMC
December 2015

Phase I Study of Ceritinib (LDK378) in Japanese Patients with Advanced, Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer or Other Tumors.

J Thorac Oncol 2015 Jul;10(7):1058-66

*The Cancer Institute Hospital of JFCR, Tokyo, Japan; †Shizuoka Cancer Center, Shizuoka, Japan; ‡National Kyushu Cancer Center, Fukuoka, Japan; §Novartis Pharma K.K., Tokyo, Japan; ¶Novartis Pharmaceuticals Corporation, East Hanover, New Jersey; and ‖Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000566DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467585PMC
July 2015

Feasibility of cisplatin/pemetrexed with 15 mg/kg bevacizumab for the treatment of patients with advanced non-squamous non-small cell lung cancer.

Oncol Lett 2015 Jun 30;9(6):2577-2582. Epub 2015 Mar 30.

Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Fukuoka 811-1395, Japan ; Clinical Research Institute, National Kyushu Cancer Center, Fukuoka, Fukuoka 811-1395, Japan.

View Article

Download full-text PDF

Source
https://www.spandidos-publications.com/10.3892/ol.2015.3086
Publisher Site
http://dx.doi.org/10.3892/ol.2015.3086DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473666PMC
June 2015

Tolerability of nintedanib (BIBF 1120) in combination with docetaxel: a phase 1 study in Japanese patients with previously treated non-small-cell lung cancer.

J Thorac Oncol 2015 Feb;10(2):346-52

*Department of Medical Oncology, Kinki University Faculty of Medicine, Osaka, Japan; †Center for Clinical and Translational Research, Faculty of Medicine, Kyusyu University Hospital, Fukuoka, Japan; ‡Department of Internal Medicine, Suita Municipal Hospital, Osaka, Japan; §Department of Medical Oncology, Nara Hospital, Kinki University Faculty of Medicine, Nara, Japan; ║Department of Medicine, Division of Respirology, Neurology, and Rheumatology, Kurume University Hospital, Fukuoka, Japan; ¶Department of Medical Oncology, Kishiwada Municipal Hospital, Osaka, Japan; #Department of Thoracic Oncology, Kansai Medical University, Hirakata Hospital, Osaka, Japan; **Department of Medical Oncology, National Kyushu Cancer Centre, Fukuoka, Japan; ††Department of Medical Oncology, National Kyushu Cancer Centre, Fukuoka, Japan; ‡‡Nippon Boehringer Ingelheim Co. Ltd., Medical Development Division, Hyogo, Japan; and §§Clinical Pharmacokinetics/Pharmacodynamics Department, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000395DOI Listing
February 2015

Anaplastic lymphoma kinase rearrangement in lung cancer: its biological and clinical significance.

Respir Investig 2014 Nov 30;52(6):330-8. Epub 2014 Jul 30.

Department of Thoracic Oncology, National Kyushu Cancer Center, 3-1-1 Notame, Minami-ku, Fukuoka 811-1395, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.resinv.2014.06.005DOI Listing
November 2014

Results of S-1-based chemotherapy for platinum (and antrathycline)-refractory advanced thymic carcinoma.

Anticancer Res 2014 Oct;34(10):5743-7

Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan Clinical Research Institute, National Kyushu Cancer Center, Fukuoka, Japan.

View Article

Download full-text PDF

Source
October 2014